Organogenesis Holdings Inc. (FRA:2PQ)
4.280
+0.120 (2.88%)
Last updated: Dec 5, 2025, 5:00 PM CET
Organogenesis Holdings Revenue
Organogenesis Holdings had revenue of $150.86M USD in the quarter ending September 30, 2025, with 30.98% growth. This brings the company's revenue in the last twelve months to $465.22M, up 2.24% year-over-year. In the year 2024, Organogenesis Holdings had annual revenue of $482.04M with 11.29% growth.
Revenue (ttm)
$465.22M
Revenue Growth
+2.24%
P/S Ratio
1.30
Revenue / Employee
$535.35K
Employees
869
Market Cap
517.10M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 482.04M | 48.90M | 11.29% |
| Dec 31, 2023 | 433.14M | -17.75M | -3.94% |
| Dec 31, 2022 | 450.89M | -16.47M | -3.52% |
| Dec 31, 2021 | 467.36M | 129.06M | 38.15% |
| Dec 31, 2020 | 338.30M | 77.32M | 29.63% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Organogenesis Holdings News
- 4 weeks ago - Organogenesis (ORGO) Q3 Earnings Exceed Expectations with Strong Product Sales - GuruFocus
- 4 weeks ago - Organogenesis outlines 2025 revenue guidance of $500M–$525M as CMS policy shift drives growth outlook - Seeking Alpha
- 4 weeks ago - Organogenesis Holdings Inc. (ORGO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Organogenesis Stock Surges 54% After Q3 Revenue Beat And Guidance Raise - Nasdaq
- 4 weeks ago - Organogenesis Holdings Inc (ORGO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 4 weeks ago - Q3 2025 Organogenesis Holdings Inc Earnings Call Transcript - GuruFocus
- 4 weeks ago - Organogenesis Holdings Inc (ORGO) Q3 2025 Earnings: EPS of $0. ... - GuruFocus
- 4 weeks ago - Organogenesis Holdings GAAP EPS of $0.11 beats by $0.05, revenue of $150.5M beats by $16.4M - Seeking Alpha